« Home | Mesothelioma - Lung cancer apoptosis enhanced by adenylate cyclase toxin » | Mesothelioma - Exposure To Volcanic Mineral Associated With Increased Mesothelioma Incidence In Turkey » | Mesothelioma - Alfacell Corporation Reports Second Quarter 2006 Financial Results ... » | Mesothelioma News - Fears over shake-up of asbestos payments » | Mesothelioma News - ALCOA asbestos suit dismissed - Employee moves forward with appeal (03 » | Mesothelioma News - Asbestos Workers Union Joins New Medical Foundation's Quest for Cure of Asbestos and Benzene-Related Cancers » | Mesothelioma News - Now army checks for asbestos » | Mesothelioma News - Anglers vie for boat package while helping out » | Mesothelioma News - Litigation, Arbitration and Dispute Resolution » | Mesothelioma News - Speak Out ... Editorial on Cheneys aim hit the mark » 

Wednesday, May 03, 2006

Mesothelioma - Deaths


Deaths
Austin, Irene M.; 101; Evansville; died 3/23; respiratory failure, Alzheimer's disease. Brown, Betty Frances; 69; Evansville; died 3/18; end stage chronic obstructive pulmonary disease.

Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
Alfacell Corporation today announced that the 210 events has been reached in its confirmatory Phase IIIb registration trial evaluating ONCONASE , the Company's lead investigational drug candidate, as a treatment for unresectable malignant mesothelioma .

E-mail this post



Remember me (?)



All personal information that you provide here will be governed by the Privacy Policy of Blogger.com. More...